Hemophilia AFactor VIII deficiency; Classic hemophilia; Bleeding disorder - hemophilia A
Hemophilia A is a hereditary bleeding disorder caused by a lack of blood clotting factor VIII. Without enough factor VIII, the blood cannot clot properly to control bleeding.
Bleeding disorders are a group of conditions in which there is a problem with the body's blood clotting process. These disorders can lead to heavy a...
When you bleed, a series of reactions take place in the body that helps blood clots form. This process is called the coagulation cascade. It involves special proteins called coagulation, or clotting, factors. You may have a higher chance of excess bleeding if one or more of these factors are missing or are not functioning like they should.
Factor VIII (eight) is 1 such coagulation factor. Hemophilia A is the result of the body not making enough factor VIII.
Hemophilia A is caused by an inherited X-linked recessive trait, with the defective gene located on the X chromosome. Females have 2 copies of the X chromosome. So if the factor VIII gene on 1 chromosome does not work, the gene on the other chromosome can do the job of making enough factor VIII.
Sex-linked diseases are passed down through families through one of the X or Y chromosomes. X and Y are sex chromosomes. Dominant inheritance occur...
Males have only 1 X chromosome. If the factor VIII gene is missing on a boy's X chromosome, he will have hemophilia A. For this reason, most people with hemophilia A are male.
If a woman has a defective factor VIII gene, she is considered a carrier. This means the defective gene can be passed down to her children. Boys born to such women have a 50% chance of having hemophilia A. Their daughters have a 50% chance of being a carrier. All female children of men with hemophilia carry the defective gene. Risk factors for hemophilia A include:
- Family history of bleeding
- Being male
Severity of symptoms vary. Prolonged bleeding is the main symptom. It is often first seen when an infant is circumcised. Other bleeding problems usually show up when the infant starts crawling and walking.
Bleeding is the loss of blood. Bleeding may be:Inside the body (internally) Outside the body (externally)Bleeding may occur:Inside the body when blo...
Mild cases may go unnoticed until later in life. Symptoms may first occur after surgery or injury. Internal bleeding may occur anywhere.
Symptoms can include:
- Bleeding into joints with associated pain and swelling
- Blood in the urine or stool
- Gastrointestinal tract and urinary tract bleeding
- Prolonged bleeding from cuts, tooth extraction, and surgery
- Bleeding that starts without cause
Exams and Tests
If you are the first person in the family to have a suspected bleeding disorder, your health care provider will order a series of tests called a coagulation study. Once the specific defect has been identified, other people in your family will need tests to diagnose the disorder.
Tests to diagnose hemophilia A include:
- Prothrombin time
- Bleeding time
- Fibrinogen level
- Partial thromboplastin time ( PTT )
- Serum factor VIII activity
Treatment includes replacing the missing clotting factor. You will receive factor VIII concentrates. How much you get depends on:
- Severity of bleeding
- Site of bleeding
- Your weight and height
Mild hemophilia may be treated with desmopressin (DDAVP). This medicine helps the body release factor VIII that is stored within the lining of blood vessels.
To prevent a bleeding crisis, people with hemophilia and their families can be taught to give factor VIII concentrates at home at the first signs of bleeding. People with severe forms of the disease may need regular preventive treatment.
DDAVP or factor VIII concentrate may also be needed before having dental extractions or surgery.
You should get the hepatitis B vaccine . People with hemophilia are more likely to get hepatitis B because they may receive blood products.
Hepatitis B vaccine
All content below is taken in its entirety from the CDC Hepatitis B Vaccine Information Statement (VIS): www. cdc. gov/vaccines/hcp/vis/vis-statement...
Some people with hemophilia A develop antibodies to factor VIII. These antibodies are called inhibitors. The inhibitors attack factor VIII so that it no longer works. In such cases, a man-made clotting factor called VIIa can be given.
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include micr...
You can ease the stress of illness by joining a h emophilia support group . Sharing with others who have common experiences and problems can help you not feel alone.
Emophilia support group
The following organizations provide further information on hemophilia:Centers for Disease Control and Prevention -- www. cdc. gov/ncbddd/hemophilia/i...
With treatment, most people with hemophilia A are able to lead a fairly normal life.
If you have hemophilia A, you should have regular checkups with a hematologist.
Complications may include:
- Long-term joint problems, which may require a joint replacement
- Bleeding in the brain (intracerebral hemorrhage)
- Blood clots due to treatment
When to Contact a Medical Professional
Call your provider if:
- Symptoms of a bleeding disorder develops
- A family member has been diagnosed with hemophilia A
- You have hemophilia A and you plan to have children; genetic counseling is available
Genetic counseling may be recommended. Testing can identify women and girls who carry the hemophilia gene. Identify women and girls who carry the hemophilia gene.
Testing can be done during pregnancy on a baby in the mother's womb.
Carcao M, Moorehead P, Lillicrap D. Hemophilia A and B. In: Hoffman R, Benz EJ, Silberstein LE, Heslop HE, Weitz JI, Anastasi J, eds. Hematology: Basic Principles and Practice . 6th ed. Philadelphia, PA: Elsevier Saunders; 2013:chap 137.
Scott JP, Flood VH. Hereditary clotting factor deficiencies (bleeding disorders). In: Kliegman RM, Stanton BF, St Geme JW, Schor NF, eds. Nelson Textbook of Pediatrics . 20th ed. Philadelphia, PA: Elsevier; 2016:chap 476.
Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia. Haemophilia. 2013;19:e1-47. PMID: 22776238 www.ncbi.nlm.nih.gov/pubmed/22776238 ..
Review Date: 2/1/2016
Reviewed By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.